HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined oral contraceptives in women with menstrual migraine without aura.

AbstractOBJECTIVE:
To compare the efficacy of two regimens (21 active pills + 7 placebo pills vs. 24 active pills + 4 placebo pills) of combined oral contraception (COC), both containing 20 μg of ethinyl E(2) and 3 mg of drospirenone, in improving the severity of pure menstrual migraine without aura.
DESIGN:
Prospective randomized study.
SETTING:
Patients attending the gynecology department of the University of Siena for consultation regarding an appropriate contraception.
PATIENT(S):
Women ages 20 to 35 years (n = 60) suffering from pure menstrual migraine without aura.
INTERVENTION(S):
Three months of contraceptive use (ethinyl E(2) 20 μg/drospirenone 3 mg) in two different regimens: group A received 21 active + 7 placebo pills whereas group B received 24 active + 4 placebo pills.
MAIN OUTCOME MEASURE(S):
Monthly evaluation of the duration and severity of patients' daily headache attacks.
RESULT(S):
Although both study groups demonstrated significant reduction in the intensity and duration of menstrual migraine, patients in group B (24/4 COC) reported a significant reduction in the intensity and a shorter duration of their menstrual migraine, compared with group A (21/7 COC).
CONCLUSION(S):
The 24/4 COC regimen is recommended as the preferred treatment for patients suffering from pure menstrual migraine without aura.
AuthorsVincenzo De Leo, Valeria Scolaro, Maria Concetta Musacchio, Alessandra Di Sabatino, Giuseppe Morgante, Antonio Cianci
JournalFertility and sterility (Fertil Steril) Vol. 96 Issue 4 Pg. 917-20 (Oct 2011) ISSN: 1556-5653 [Electronic] United States
PMID21843889 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Contraceptives, Oral, Combined
Topics
  • Adult
  • Contraceptives, Oral, Combined (administration & dosage)
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Humans
  • Menstruation (drug effects, physiology)
  • Migraine without Aura (diagnosis, drug therapy, physiopathology)
  • Prospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: